Story thread · 3 reports / 3 sources

AbCellera, Vertex partner on next-gen T-cell engagers

biopharmadive.com · 13dShare

The deal adds to a growing streak of partnerships involving new types of T cell engagers and gives Vertex another chance to broaden a business still reliant on cystic fibrosis medicines.

First report: AbCellera Announces Collaboration with Vertex to Discover Multispecific T-Cell Engagers for Autoimmune Diseases and Other Conditions — financialpost.com, 13d